샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768559

세계의 면역침강 시장

Immunoprecipitation
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 279 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 면역침강 시장은 2030년까지 10억 달러에 달할 전망

2024년에 7억 1,600만 달러로 추정되는 세계의 면역침강 시장은 2024-2030년에 CAGR 5.8%로 성장하며, 2030년에는 10억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 시약은 CAGR 5.9%를 기록하며, 분석 기간 종료시에는 4억 5,790만 달러에 달할 것으로 예측됩니다. 키트 부문의 성장률은 분석 기간 중 CAGR 6.5%로 추정됩니다.

미국 시장은 추정 1억 8,610만 달러, 중국은 CAGR 9.0%로 성장 예측

미국의 면역침강 시장은 2024년에는 1억 8,610만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 9.0%로 추이하며, 2030년에는 2억 3,250만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.5%와 4.6%로 예측됩니다. 유럽에서는 독일이 CAGR 4.1%로 성장할 것으로 예측됩니다.

세계의 면역침강 시장 - 주요 동향과 촉진요인 정리

분자생물학 연구에 면역침강이 필수적인 이유는 무엇인가?

면역침강(IP)은 분자생물학 및 생화학에서 복잡한 생물학적 샘플에서 특정 단백질을 분리하여 연구하는 데 사용되는 중요한 기술입니다. 원하는 단백질에 특이적으로 결합하는 항체를 사용하여 연구자는 단백질을 "풀다운"하여 추가 연구를 위해 분석할 수 있습니다. 면역침강은 단백질 간 상호작용, 번역 후 변형, 신호전달 경로 연구에 널리 사용되고 있으며, 암 연구, 의약품 개발, 기초 생물학 연구에서 매우 중요한 툴이 되고 있습니다. 면역침강은 단백질을 원래의 상태로 조사할 수 있는 수단을 제공함으로써 세포 기능 및 질병 메커니즘에 대한 인사이트를 제공하고, 연구자들이 잠재적인 치료 표적을 식별하고 질병 진행을 더 잘 이해할 수 있도록 돕습니다.

기술 혁신은 어떻게 면역침강 시장을 형성하고 있는가?

항체, 시약 및 검출 방법의 기술 발전은 면역침강 기술의 정확성, 효율성 및 신뢰성을 향상시켰습니다. 고친화도 단클론 항체 및 재조합 항체의 개발로 IP 분석의 특이성과 재현성이 크게 향상되어 연구자들은 더 높은 정확도로 단백질을 표적으로 삼을 수 있게 되었습니다. 또한 자기 비드와 가교 시약의 발전으로 면역 침전 과정이 단순화되고, 배경 잡음이 감소하고, 표적 단백질의 수율이 향상되었습니다. 또한 질량분석과 면역 침전(IP-MS)의 통합은 단백질의 동정과 정량을 동시에 가능하게 하여 단백질 복합체 및 신호 전달 네트워크에 대한 더 깊은 인사이트를 제공함으로써 이 분야에 혁명을 일으켰습니다. 이러한 기술 혁신으로 인해 단백질체학, 신약개발, 바이오마커 연구에 면역침강이 광범위하게 적용되고 있습니다.

시장 세분화는 면역 침전 산업의 성장을 어떻게 규정하는가?

면역침강에는 크로마틴 면역침강(ChIP), 공동 면역침강(Co-IP), RNA 면역침강(RIP)이 있으며, 공동 면역침강은 단백질 간 상호작용을 연구할 수 있으므로 가장 널리 사용되고 있습니다. 면역침전은 신약개발, 단백질체학 연구, 질병 진단에 적용되며, 단백질체학 연구는 질병 메커니즘을 이해하기 위한 단백질 상호작용 연구에 대한 수요 증가로 인해 가장 큰 시장 점유율을 차지하고 있습니다. 최종사용자에는 학술연구기관, 제약회사, CRO(의약품 개발 위탁기관) 등이 포함되며, 제약회사는 신약개발 및 연구개발 과정에서 IP 활용을 늘리고 있으며, 수요를 견인하고 있습니다.

면역침강 시장의 성장을 가속하는 요인은 무엇인가?

면역 침전 시장의 성장은 단백질체학 연구에 대한 수요 증가, 항체 기술의 발전, 신약 개발 및 바이오마커 식별에 대한 관심 증가 등 여러 가지 요인에 기인합니다. 연구자들이 단백질의 상호작용과 질병에서의 역할을 이해하는 데 집중함에 따라 신뢰할 수 있는 면역침강 기술에 대한 수요가 증가하고 있습니다. 보다 특이적인 항체 및 개선된 시약의 개발과 같은 기술 발전으로 IP는 더욱 친숙하고 효율적이 되었습니다. 질량분석기 및 기타 첨단 검출 방법의 통합은 복잡한 단백질 네트워크에 대한 연구 능력을 향상시켜 학술연구 및 제약 연구에서의 IP 채택을 촉진하고 있습니다. 또한 암 연구와 맞춤 의료 분야에서 IP의 활용이 증가하면서 시장 확대에 기여하고 있습니다.

부문

컴포넌트(시약, 키트, 부속품); 최종 사용(학술·연구기관, 제약·바이오파마 기업, 계약 연구기관)

조사 대상 기업의 예

  • Abbkine Scientific Co. Ltd.
  • Abcam PLC
  • BioLegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology Inc.
  • Geno Technology Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.17

Global Immunoprecipitation Market to Reach US$1.0 Billion by 2030

The global market for Immunoprecipitation estimated at US$716.0 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$457.9 Million by the end of the analysis period. Growth in the Kits segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$186.1 Million While China is Forecast to Grow at 9.0% CAGR

The Immunoprecipitation market in the U.S. is estimated at US$186.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$232.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Immunoprecipitation Market - Key Trends and Drivers Summarized

Why Is Immunoprecipitation Essential in Molecular Biology Research?

Immunoprecipitation (IP) is a critical technique used in molecular biology and biochemistry to isolate and study specific proteins from complex biological samples. It involves using an antibody that specifically binds to the protein of interest, allowing researchers to “pull down” the protein and analyze it for further study. Immunoprecipitation is widely used for studying protein-protein interactions, post-translational modifications, and signaling pathways, making it an invaluable tool in cancer research, drug development, and basic biological research. By providing a means to study proteins in their native state, immunoprecipitation offers insights into cellular functions and disease mechanisms, helping researchers identify potential therapeutic targets and better understand disease progression.

How Are Technological Innovations Shaping the Immunoprecipitation Market?

Technological advancements in antibodies, reagents, and detection methods are enhancing the precision, efficiency, and reliability of immunoprecipitation techniques. The development of high-affinity monoclonal antibodies and recombinant antibodies has significantly improved the specificity and reproducibility of IP assays, allowing researchers to target proteins with greater accuracy. Additionally, advancements in magnetic beads and cross-linking reagents have simplified the immunoprecipitation process, reducing background noise and improving the yield of target proteins. The integration of mass spectrometry with immunoprecipitation (IP-MS) has also revolutionized the field by enabling the simultaneous identification and quantification of proteins, providing deeper insights into protein complexes and signaling networks. These innovations are expanding the applications of immunoprecipitation in proteomics, drug discovery, and biomarker research.

How Do Market Segments Define the Growth of the Immunoprecipitation Industry?

Types of immunoprecipitation include chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Co-IP), and RNA immunoprecipitation (RIP), with co-immunoprecipitation being the most widely used due to its ability to study protein-protein interactions. Applications of immunoprecipitation span across drug discovery, proteomics research, and disease diagnostics, with proteomics research holding the largest market share due to the growing demand for protein interaction studies in understanding disease mechanisms. End-users include academic research institutes, pharmaceutical companies, and contract research organizations (CROs), with pharmaceutical companies driving demand as they increasingly use IP in drug discovery and development processes.

What Factors Are Driving the Growth in the Immunoprecipitation Market?

The growth in the immunoprecipitation market is driven by several factors, including the rising demand for proteomics research, advancements in antibody technologies, and the growing focus on drug discovery and biomarker identification. As researchers focus on understanding protein interactions and their role in disease, the demand for reliable immunoprecipitation techniques is increasing. Technological advancements, such as the development of more specific antibodies and improved reagents, are making IP more accessible and efficient. The integration of mass spectrometry and other advanced detection methods is also enhancing the ability to study complex protein networks, driving the adoption of IP in academic and pharmaceutical research. Furthermore, the increasing use of IP in cancer research and personalized medicine is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Immunoprecipitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents, Kits, Accessories); End-Use (Academic & Research Institutes, Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbkine Scientific Co. Ltd.
  • Abcam PLC
  • BioLegend
  • Bio-Rad Laboratories
  • Cell Signaling Technology Inc.
  • Geno Technology Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Immunoprecipitation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Immunoprecipitation in Protein Purification and Analysis Expands Market Opportunities
    • Rising Demand for Immunoprecipitation in Biomedical and Clinical Research Drives Market Growth
    • Technological Advancements in Immunoprecipitation Kits and Reagents Strengthen Product Innovation
    • Increasing Focus on Precision Medicine and Personalized Therapies Fuels Demand for Immunoprecipitation Techniques
    • Rising Adoption of Immunoprecipitation in Epigenetics and Chromatin Studies Boosts Market Demand
    • Expansion of Immunoprecipitation Applications in Cancer Research and Proteomics Propels Market Growth
    • Growing Use of Immunoprecipitation in Drug Discovery and Development Strengthens the Business Case
    • Technological Innovations in Magnetic Bead-Based Immunoprecipitation Drives Product Differentiation
    • Rising Focus on Targeted Protein Interaction Studies Expands the Scope of Immunoprecipitation Techniques
    • Growing Interest in Immunoprecipitation for Post-Translational Modification Studies Spurs Demand
    • Expansion of Immunoprecipitation in Stem Cell Research and Regenerative Medicine Creates New Opportunities
    • Increasing Automation and High-Throughput Capabilities in Immunoprecipitation Strengthen Market Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Immunoprecipitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Immunoprecipitation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • CHINA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Immunoprecipitation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Immunoprecipitation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • INDIA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Immunoprecipitation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Immunoprecipitation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
  • AFRICA
    • Immunoprecipitation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Immunoprecipitation by Component - Reagents, Kits and Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Immunoprecipitation by Component - Reagents, Kits and Accessories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Immunoprecipitation by Component - Percentage Breakdown of Value Sales for Reagents, Kits and Accessories for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Immunoprecipitation by End-Use - Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Immunoprecipitation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제